Samsung Biologics to launch $1.8 billion all-cash bid for polypeptidesreuters
Samsung Biologics makes $1.8 billion cash offer for Switzerland’s Polypeptide Groupcnbc
Samsung Biologics to buy polypeptide in $1.8 billion dealbloomberg.com
Polypeptide Group says Samsung Biologics has announced a tender offer to acquire Polypeptide Group AG at CHF 44.31 per share.trading view
Samsung Biologics has announced an all-cash offer to acquire Polypeptide, accelerating multi-modality strategy and expanding global network in the US, Europe and India.cbs19news.com
